Alemtuzumab (Campath-1H) induction in a pediatric heart transplant: Successful outcome and rationale for its use

被引:16
作者
Das, Bibhuti [1 ]
Shoemaker, Lawrence [2 ]
Recto, Michael [1 ]
Austin, Erle [3 ]
Dowling, Robert [3 ]
机构
[1] Univ Louisville, Dept Pediat, Div Cardiol, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Pediat, Div Nephrol, Louisville, KY 40202 USA
[3] Univ Louisville, Dept Surg, Div Cardiothorac Surg, Louisville, KY 40202 USA
关键词
D O I
10.1016/j.healun.2007.11.569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite increasing clinical experience in adult transplantation, induction therapy with alemtuzumab (Campath-1H) has rarely been reported in pediatric solid-organ transplants, and has been limited to kidneys, intestine and multi-visceral organs. Basic science research and clinical observations reported from the adult experience suggest potential benefits of alemtuzumab in pediatric organ recipients. We report successful induction therapy with alemtuzumab and steroid-free maintenance therapy for cardiac transplantation in a teenager, and discuss its merits in this patient.
引用
收藏
页码:242 / 244
页数:3
相关论文
共 15 条
[1]   Campath-1H use in pediatric renal transplantation [J].
Bartosh, SM ;
Knechtle, SJ ;
Sollinger, HW .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (06) :1569-1573
[2]   Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients [J].
Calne, R ;
Friend, P ;
Moffatt, S ;
Bradley, A ;
Hale, G ;
Firth, J ;
Bradley, J ;
Smith, K ;
Waldmann, H .
LANCET, 1998, 351 (9117) :1701-1702
[3]   A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring [J].
Ciancio, G ;
Burke, GW ;
Gaynor, JJ ;
Carreno, MR ;
Cirocco, RE ;
Mathew, JM ;
Mattiazzi, A ;
Cordovilla, T ;
Roth, D ;
Kupin, W ;
Rosen, A ;
Esquenazi, V ;
Tzakis, AG ;
Miller, J .
TRANSPLANTATION, 2005, 80 (04) :457-465
[4]   Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis [J].
Coles, AJ ;
Wing, N ;
Smith, S ;
Coraddu, F ;
Greer, S ;
Taylor, C ;
Weetman, A ;
Hale, G ;
Chatterjee, VK ;
Waldmann, H ;
Compston, A .
LANCET, 1999, 354 (9191) :1691-1695
[5]   The CD52 antigen and development of the CAMPATH antibodies [J].
Hale, G .
CYTOTHERAPY, 2001, 3 (03) :137-143
[6]   Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants [J].
Hale, G ;
Wardman, H .
BLOOD, 1998, 91 (08) :3079-3083
[7]   Intestinal transplantation in children: A summary of clinical outcomes and prognostic factors in 108 patients from a single center [J].
Kato, T ;
Gaynor, JJ ;
Selvaggi, G ;
Mittal, N ;
Thompson, J ;
McLaughlin, GE ;
Nishida, S ;
Moon, J ;
Levi, D ;
Madariaga, J ;
Ruiz, P ;
Tzakis, A .
JOURNAL OF GASTROINTESTINAL SURGERY, 2005, 9 (01) :75-89
[8]   Intestinal and multivisceral transplantation in children [J].
Kato, Tomoaki ;
Tzakis, Andreas G. ;
Selvaggi, Gennaro ;
Gaynor, Jeffrey J. ;
David, Andre I. ;
Bussotti, Alessandro ;
Moon, Jang I. ;
Ueno, Takehisa ;
DeFaria, Werviston ;
Santiago, Sergio ;
Levi, David M. ;
Nishida, Seigo ;
Velasco, Monica L. ;
McLaughlin, Gwen ;
Hernandez, Erick ;
Thompson, John F. ;
Cantwell, Patricia ;
Holliday, Norman ;
Livingstone, Alan S. ;
Ruiz, Phillip .
ANNALS OF SURGERY, 2006, 243 (06) :756-766
[9]   Campath-1H induction and the incidence of infectious complications in adult renal transplantation [J].
Malek, SK ;
Obmann, MA ;
Gotoff, RA ;
Foltzer, MA ;
Hartle, JE ;
Potdar, S .
TRANSPLANTATION, 2006, 81 (01) :17-20
[10]   Campath-1H therapy for resistant rejection in pediatric heart transplant patients [J].
Miyamoto, S. D. ;
Gilbert, D. ;
Ballard, A. ;
Anderson, S. ;
Le, P. N. ;
MitchelL, M. B. ;
Campbell, D. N. ;
Pietra, B. A. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02) :S246-S247